Article
Exploration of novel mechanisms of azole resistance in Candida auris.
Antimicrobial agents and chemotherapy - 5 Dec 2024
Li Jizhou, Brandalise Danielle, Coste Alix T, Sanglard Dominique, Lamoth Frederic
Abstract excerpt
Candida auris is a pathogenic yeast of particular concern because of its ability to cause nosocomial outbreaks of invasive candidiasis (IC) and to develop resistance to all current antifungal drug classes. Most C. auris clinical isolates are resistant to fluconazole, an azole drug that is used for the treatment of IC. Azole resistance may arise from diverse mechanisms, such as mutations of the target gene (ERG11)...
Topics
Join the communities discussing this publication.
